QQ客服 官方微博 反馈留言

	Efficacy and safety of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and moderate renal function impairment: A systematic review and meta-analysis
	Zhang, Lin[1,2]; Zhang, Mei[3]; Lv, Qingguo[1]; Tong, Nanwei[1]
	2018
卷号	140页码:295-303
URL标识	查看原文
WOS记录号	WOS:000434107600034
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4321472
专题	成都中医药大学
作者单位	1.[1]Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu 610000, Sichuan, Peoples R China 2.[2]Chengdu Univ Tradit Chinese Med, Affiliated Hosp 3, Diabet Mellitus Prevent & Control Ctr Sichuan Pro, Chengdu, Sichuan, Peoples R China 3.[3]Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610000, Sichuan, Peoples R China
推荐引用方式 GB/T 7714	Zhang, Lin[1,2],Zhang, Mei[3],Lv, Qingguo[1],et al. Efficacy and safety of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and moderate renal function impairment: A systematic review and meta-analysis[J],2018,140:295-303.
APA	Zhang, Lin[1,2],Zhang, Mei[3],Lv, Qingguo[1],&Tong, Nanwei[1].(2018).Efficacy and safety of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and moderate renal function impairment: A systematic review and meta-analysis.,140,295-303.
MLA	Zhang, Lin[1,2],et al."Efficacy and safety of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and moderate renal function impairment: A systematic review and meta-analysis".140(2018):295-303.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。